Pharming Group Competitors and Similar CompaniesClear all

Protalix BioTherapeutics's competitors and similar companies include Five Prime Therapeutics.
Protalix BioTherapeutics
Protalix BioTherapeutics
Protalix is a biopharmaceutical company focused on the development, production, and commercialization of recombinant therapeutic proteins.
Five Prime Therapeutics
Five Prime Therapeutics
Five Prime Therapeutics is a biotechnology company focused on developing immuno-oncology and targeted cancer therapies.
Founding Date
Founding Date
1994
Founding Date
2001
Type
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Karmiel, IL HQ
Locations
South San Francisco, US HQ
Employees
Employees
213
Employees
5141% decrease

Financial

Revenue (est.)
Revenue (est.)
$52.7m (FY, 2025)
Revenue (est.)
$13.2m (FY, 2020)
Net income
Net income
($6.6m) (FY, 2025)
Net income
($84.3m) (FY, 2020)

Funding

Total funding raised
Total funding raised
$ 62.5m
Total funding raised
$ 237.2m
For sources of this data, please see the company profile

View Company Profiles

Five Prime Therapeutics
HQ
South San Francisco, US

Five Prime Therapeutics is a biotechnology company focused on developing immuno-oncology and targeted cancer therapies.

View company